Mangsuo Zhao
Mangsuo Zhao has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Bingxin Shi
Brain Science Center, Tsinghua University Yuquan Hospital, Beijing, PR China
3 shared publicationsFangjie Huang
Department of Neurology, Yuquan Hospital, School of Clinical Medicine, Tsinghua University, No.5 Shijingshan Road, Beijing 100049, PR China
2 shared publications- Liyan Qiao
Department of Neurology, Tsinghua University Yuquan Hospital
2 shared publications Shimei Zhou
Department of Neurology, Yuquan Hospital, School of Clinical Medicine, Tsinghua University, No.5 Shijingshan Road, Beijing 100049, PR China
2 shared publicationsJing Wang
Department of Neurology, Yuquan Hospital, School of Clinical Medicine, Tsinghua University, No.5 Shijingshan Road, Beijing 100049, PR China
1 shared publication- Jing Wang
Department of Rheumatology and Immunology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China
1 shared publication
Latest Publications
- Open Access
- 19 April 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-5
Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report
Background: Loss of heterozygosity (LOH) at methylenetetrahydrofolate reductase (MTHFR) locus has been reported in tumor tissue. But the mutation was never reported in cerebral venous thrombosis (CVT) with hyperhomocysteinemia (HHcy) before. Case presentation: A 14-year-old girl was admitted with an intermittent headache and nausea for 2 months. The plasma homocysteine level was 77.2 µmol/L. Lumbar puncture revealed an intracranial pressure > 330 mmH2O. Cerebral MRI and MRV revealed superior sagittal sinus thrombosis. Whole-exome sequencing revealed LOH at Chr1:11836597–11,867,232 affects exons 10–21 of C1orf167, the entire MTHFR, and exons 1–2 of the CLCN6 gene. The normal allele was the c.665 C > T/677 C > T variant in MTHFR. The patient was treated with nadroparin for 2 weeks, followed by oral rivaroxaban. Supplemental folate and vitamins B12 and B6 were prescribed. One month later, she had no headache and the intracranial pressure had decreased to 215 mmH2O. MRI showed shrinkage of the thrombosis in the superior sagittal sinus, the degree of stenosis had significantly decreased. Conclusions: Rare LOH at the MTHFR locus should be analyzed in CVT with HHcy. With anticoagulation treatment, the prognosis was good.
- 19 April 2023
- Published by Springer Nature in BMC Neurology
- Vol. 23 (1) , 1-5
Open AccessCerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report
Background: Loss of heterozygosity (LOH) at methylenetetrahydrofolate reductase (MTHFR) locus has been reported in tumor tissue. But the mutation was never reported in cerebral venous thrombosis (CVT) with hyperhomocysteinemia (HHcy) before. Case presentation: A 14-year-old girl was admitted with an intermittent headache and nausea for 2 months. The plasma homocysteine level was 77.2 µmol/L. Lumbar puncture revealed an intracranial pressure > 330 mmH2O. Cerebral MRI and MRV revealed superior sagittal sinus thrombosis. Whole-exome sequencing revealed LOH at Chr1:11836597–11,867,232 affects exons 10–21 of C1orf167, the entire MTHFR, and exons 1–2 of the CLCN6 gene. The normal allele was the c.665 C > T/677 C > T variant in MTHFR. The patient was treated with nadroparin for 2 weeks, followed by oral rivaroxaban. Supplemental folate and vitamins B12 and B6 were prescribed. One month later, she had no headache and the intracranial pressure had decreased to 215 mmH2O. MRI showed shrinkage of the thrombosis in the superior sagittal sinus, the degree of stenosis had significantly decreased. Conclusions: Rare LOH at the MTHFR locus should be analyzed in CVT with HHcy. With anticoagulation treatment, the prognosis was good.
- 1 September 2021
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 54, 103143
Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder
- 1 September 2021
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 54, 103143
Relapses shortly after rituximab treatment in neuromyelitis optica spectrum disorder
- 7 September 2020
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 132 (4) , 370-377
Transverse myelitis associated with primary biliary cirrhosis: clinical, laboratory, and neuroradiological features
Only five patients diagnosed with transverse myelitis (TM) associated with primary biliary cirrhosis (PBC) have been reported in the literature to date. We report two additional patients with TM as...
- 7 September 2020
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 132 (4) , 370-377
Transverse myelitis associated with primary biliary cirrhosis: clinical, laboratory, and neuroradiological features
Only five patients diagnosed with transverse myelitis (TM) associated with primary biliary cirrhosis (PBC) have been reported in the literature to date. We report two additional patients with TM as...